173 related articles for article (PubMed ID: 7683218)
21. Acute myeloid leukemia possibly producing thrombopoietic factor(s).
Fujita A; Matsuoka M; Shimonaka Y; Imai N; Asano S
Jpn J Clin Oncol; 1993 Dec; 23(6):366-72. PubMed ID: 7506802
[TBL] [Abstract][Full Text] [Related]
22. Acute monocytic leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the Eastern Cooperative Oncology Group.
Tallman MS; Kim HT; Paietta E; Bennett JM; Dewald G; Cassileth PA; Wiernik PH; Rowe JM;
J Clin Oncol; 2004 Apr; 22(7):1276-86. PubMed ID: 14970186
[TBL] [Abstract][Full Text] [Related]
23. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC
Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939
[TBL] [Abstract][Full Text] [Related]
24. Assessment of the value of immunohistochemistry in the subtyping of acute leukemia on routinely processed bone marrow biopsy specimens with particular reference to macrophage-associated antibodies.
Horny HP; Wehrmann M; Steinke B; Kaiserling E
Hum Pathol; 1994 Aug; 25(8):810-4. PubMed ID: 8056422
[TBL] [Abstract][Full Text] [Related]
25. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
[TBL] [Abstract][Full Text] [Related]
26. Normal karyotype acute myeloid leukemia with the CD7+ CD15+ CD34+ HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome.
Iriyama N; Asou N; Miyazaki Y; Yamaguchi S; Sato S; Sakura T; Maeda T; Handa H; Takahashi M; Ohtake S; Hatta Y; Sakamaki H; Honda S; Taki T; Taniwaki M; Miyawaki S; Ohnishi K; Kobayashi Y; Naoe T
Ann Hematol; 2014 Jun; 93(6):957-63. PubMed ID: 24441947
[TBL] [Abstract][Full Text] [Related]
27. Minimally differentiated acute myeloid leukemia (AML-M0): comparison of 25 cases with other French-American-British subtypes.
Venditti A; Del Poeta G; Buccisano F; Tamburini A; Cox MC; Stasi R; Bruno A; Aronica G; Maffei L; Suppo G; Simone MD; Forte L; Cordero V; Postorino M; Tufilli V; Isacchi G; Masi M; Papa G; Amadori S
Blood; 1997 Jan; 89(2):621-9. PubMed ID: 9002966
[TBL] [Abstract][Full Text] [Related]
28. Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance.
Drexler HG; Thiel E; Ludwig WD
Leukemia; 1993 Apr; 7(4):489-98. PubMed ID: 7681917
[TBL] [Abstract][Full Text] [Related]
29. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
30. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children.
Hurwitz CA; Raimondi SC; Head D; Krance R; Mirro J; Kalwinsky DK; Ayers GD; Behm FG
Blood; 1992 Dec; 80(12):3182-8. PubMed ID: 1467524
[TBL] [Abstract][Full Text] [Related]
31. The clinical characteristics of CD7+ CD56+ acute myeloid leukemias other than M0.
Suzuki R; Ohtake S; Takeuchi J; Nagai M; Kodera Y; Hamaguchi M; Miyawaki S; Karasuno T; Shimodaira S; Ohno R; Nakamura S; Naoe T
Int J Hematol; 2010 Mar; 91(2):303-9. PubMed ID: 20111912
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic significance of CD7 expression in adult acute myeloid leukemia].
Saito T; Usui N; Dobashi N; Maki N; Asai O; Yano S; Kato A; Watanabe H; Katori M; Nagamine M; Ogihara A; Yamazaki H; Kobayashi T; Tajima N; Kuraishi Y
Rinsho Ketsueki; 1998 Jul; 39(7):481-6. PubMed ID: 9750454
[TBL] [Abstract][Full Text] [Related]
33. CD7 expression in acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Masi M; Papa G
Blood; 1993 Nov; 82(9):2929-30. PubMed ID: 7693052
[No Abstract] [Full Text] [Related]
34. Clinical and biologic characteristics of CD7+ acute myeloid leukemia. Our experience and literature review.
Shimamoto T; Ohyashiki JH; Ohyashiki K; Kawakubo K; Inatomi Y; Fujieda H; Nakazawa S; Kimura N; Miyauchi J; Toyama K
Cancer Genet Cytogenet; 1994 Mar; 73(1):69-74. PubMed ID: 7513604
[TBL] [Abstract][Full Text] [Related]
35. CD7+ stem cell leukemia/lymphoma. Features of a subgroup without circulating blast cells.
Katsuno M; Abe Y; Taguchi F; Yufu Y; Sadamura S; Goto T; Takatsuki H; Nishimura J; Hirata J; Akiyoshi T
Cancer; 1993 Jul; 72(1):99-104. PubMed ID: 7685244
[TBL] [Abstract][Full Text] [Related]
36. Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity.
Cross AH; Goorha RM; Nuss R; Behm FG; Murphy SB; Kalwinsky DK; Raimondi S; Kitchingman GR; Mirro J
Blood; 1988 Aug; 72(2):579-87. PubMed ID: 3261183
[TBL] [Abstract][Full Text] [Related]
37. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
Janossy G; Coustan-Smith E; Campana D
Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
[TBL] [Abstract][Full Text] [Related]
38. CD117/CD34 expression in leukemic blasts.
Wells SJ; Bray RA; Stempora LL; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
[TBL] [Abstract][Full Text] [Related]
39. Clinical and hematological correlates of aberrant immunophenotypic profiles in adult and pediatric acute myeloid leukemia at presentation.
Sharma M; Varma N; Singh Sachdeva MU; Bose P; Varma S
J Cancer Res Ther; 2020; 16(1):105-109. PubMed ID: 32362618
[TBL] [Abstract][Full Text] [Related]
40. Acute non-lymphocytic leukemia with expression of surface antigen CD7--morphological, cytochemical, immunological and ultrastructural features in eight patients.
Chopra HK; Nair CN; Barbhaya SA; Dhond SR; Badrinath Y; Kumar A; Zachariah LV; Advani SH
Indian J Cancer; 1993 Jun; 30(2):48-54. PubMed ID: 7693579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]